Search Press releases Keywords From To 30 Nov 2018 UCB presents latest research at 2018 American Epilepsy Society Annual Meeting demonstrating neurology commitment and leadership Read More 21 Nov 2018 Transparency notifications BlackRock, Inc. Read More 29 Oct 2018 UCB First Nine Months Interim Report 2018: UCB tracking well towards full year financial outlook Read More 23 Oct 2018 Bimekizumab Showed Sustained Improvements in Both Joint and Skin Outcomes for Psoriatic Arthritis Patients Read More 22 Oct 2018 UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus Read More 18 Oct 2018 UCB Presents New Long-Term Data Showing Substantial Impact for CIMZIA® (Certolizumab Pegol) in Axial Spondyloarthritis and Rheumatoid Arthritis and Late-Breaking Bimekizumab Data in Psoriatic Arthritis Read More Pagination First page Previous page Previous … Page 64 Page 65 Page 66 Page 67 Current page 68 Page 69 Page 70 Page 71 Page 72 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
